WallStreetZenWallStreetZen

NYSE: USPH
U S Physical Therapy Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for USPH

Based on 3 analysts offering 12 month price targets for U S Physical Therapy Inc.
Min Forecast
$107.00+6.38%
Avg Forecast
$113.33+12.68%
Max Forecast
$120.00+19.31%

Should I buy or sell USPH stock?

Based on 4 analysts offering ratings for U S Physical Therapy Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
0 analysts 0%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their USPH stock forecasts and price targets.

Forecast return on equity

Is USPH forecast to generate an efficient return?
Company
13.2%
Industry
-49.96%
Market
47.78%
USPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is USPH forecast to generate an efficient return on assets?
Company
5.24%
Industry
7.85%
USPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

USPH earnings per share forecast

What is USPH's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$3.00+0.67%
Avg 2 year Forecast
$3.22+8.05%
USPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

USPH revenue forecast

What is USPH's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$568.7M+4.97%
Avg 2 year Forecast
$623.5M+15.09%
USPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

USPH earnings growth forecast

How is USPH forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
0.67%
Industry
20.05%
Market
85.2%
USPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
USPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
USPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

USPH revenue growth forecast

How is USPH forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
4.97%
Industry
9.71%
Market
72.18%
USPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
USPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

USPH vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
USPH$100.58$113.33+12.68%Strong Buy
MD$15.47$23.50+51.91%Buy
MODV$108.32$141.50+30.63%Strong Buy
INNV$7.61$5.98-21.42%Hold
DCGO$9.89$11.00+11.22%Strong Buy
View Top Medical Care Facility Stocks

U S Physical Therapy Stock Forecast FAQ

Is U S Physical Therapy Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: USPH) stock is to Strong Buy USPH stock.

Out of 4 analysts, 3 (75%) are recommending USPH as a Strong Buy, 0 (0%) are recommending USPH as a Buy, 1 (25%) are recommending USPH as a Hold, 0 (0%) are recommending USPH as a Sell, and 0 (0%) are recommending USPH as a Strong Sell.

If you're new to stock investing, here's how to buy U S Physical Therapy stock.

What is USPH's earnings growth forecast for 2023-2024?

(NYSE: USPH) U S Physical Therapy's forecast annual earnings growth rate of 0.67% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 20.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 85.2%.

U S Physical Therapy's earnings in 2023 is $39,764,000.On average, 3 Wall Street analysts forecast USPH's earnings for 2023 to be $39,004,767, with the lowest USPH earnings forecast at $37,704,608, and the highest USPH earnings forecast at $39,654,846.

In 2024, USPH is forecast to generate $41,865,117 in earnings, with the lowest earnings forecast at $41,865,117 and the highest earnings forecast at $41,865,117.

What is USPH's revenue growth forecast for 2023-2024?

(NYSE: USPH) U S Physical Therapy's forecast annual revenue growth rate of 4.97% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 72.18%.

U S Physical Therapy's revenue in 2023 is $541,795,000.On average, 3 Wall Street analysts forecast USPH's revenue for 2023 to be $7,394,211,690, with the lowest USPH revenue forecast at $7,215,881,895, and the highest USPH revenue forecast at $7,620,738,375.

In 2024, USPH is forecast to generate $8,107,101,816 in revenue, with the lowest revenue forecast at $8,107,101,816 and the highest revenue forecast at $8,107,101,816.

What is USPH's forecast return on assets (ROA) for 2023-2024?

(NYSE: USPH) forecast ROA is 5.24%, which is lower than the forecast US Medical Care Facilities industry average of 7.85%.

What is USPH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year USPH price target, the average USPH price target is $113.33, with the highest USPH stock price forecast at $120.00 and the lowest USPH stock price forecast at $107.00.

On average, Wall Street analysts predict that U S Physical Therapy's share price could reach $113.33 by Aug 5, 2023. The average U S Physical Therapy stock price prediction forecasts a potential upside of 12.68% from the current USPH share price of $100.58.

What is USPH's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: USPH) U S Physical Therapy's current Earnings Per Share (EPS) is $2.98. On average, analysts forecast that USPH's EPS will be $3.00 for 2023, with the lowest EPS forecast at $2.90, and the highest EPS forecast at $3.05. In 2024, USPH's EPS is forecast to hit $3.22 (min: $3.22, max: $3.22).

What is USPH's forecast return on equity (ROE) for 2023-2024?

(NYSE: USPH) forecast ROE is 13.2%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.